3-Methyl-6-nitroindazole a reactant used in the preparation of Pazopanib (P210925), an oral angiogenesis inhibitor targeting VEGFR and PDGFR.
Mei, Y. et al.: Let. Org. Chem., 9, 276 (2012); Harris, P. et al.: J. Med. Chem., 51, 4632 (2008); Olaussen, K., et al.: Oncogen., 28, 4249 (2009); Sleijfer, S., et al.: J. Clin. Oncol., 27, 3126 (2009); Chan, A., et al.: Drugs, 69, 167 (2009)
400-821-0725
沪ICP备17019645号
